Search Results for 'drug access'

drug access published presentations and documents on DocSlides.

FDA’s Access Mechanisms
FDA’s Access Mechanisms
by roxanne
When They Work – When They Don’t . And Why. St...
‘High’ Achievers?
‘High’ Achievers?
by giovanna-bartolotta
Cannabis Access and Academic Performance . ...
DIVISION OF MEDICAL ETHICS
DIVISION OF MEDICAL ETHICS
by jasmine
1 HIGH SCHOOL BIOETHICS PROJECT Compassionate Use ...
1 King & Spalding                                           May 22, 2014
1 King & Spalding May 22, 2014
by marina-yarberry
1 King & Spalding ...
Group 4
Group 4
by lindy-dunigan
Andrew Nicklawsky, Sarah Cusick, Zequing Lu, Anna...
Visceral Leishmaniasis treatment access: The reality on the
Visceral Leishmaniasis treatment access: The reality on the
by yoshiko-marsland
Margriet. . den . Boer. KalaCORE Regional Coordi...
Access to Sterile Syringes: Changes to California Law
Access to Sterile Syringes: Changes to California Law
by mitsue-stanley
Alessandra Ross, MPH. Injection Use Specialist. "...
Expanded Access Use of for Investigational Drugs in VA:  Focus on COVID-19
Expanded Access Use of for Investigational Drugs in VA: Focus on COVID-19
by summer
Office of Research Protections, Policy, & Educ...
Visceral Leishmaniasis treatment access: The reality on the ground
Visceral Leishmaniasis treatment access: The reality on the ground
by nicole
Margriet. . den . Boer. KalaCORE Regional Coordin...
x0000x00001  xMCIxD 0 xMCIxD 0 DEPARTMENT OF HEALTH HUMAN SERVICESCe
x0000x00001 xMCIxD 0 xMCIxD 0 DEPARTMENT OF HEALTH HUMAN SERVICESCe
by elyana
We encourageissuers offering coveragein the indivi...
Compassionate Use Navigator
Compassionate Use Navigator
by delcy
-- www.kidsvcancer.org 1 Contact: Elena Gerasimov,...
Database Access Control
Database Access Control
by Ruggedman
& . Privacy: Is There A Common Ground?. Suraji...
Comments of Prescription Access Litigation Project and Others on FTC P
Comments of Prescription Access Litigation Project and Others on FTC P
by jainy
almost-inevitable patent infringement lawsuit from...
THE ROLE OF PHARMACEUTICALS  IN PUBLIC HEALTH ACCESS TO ESSENTIAL MEDI
THE ROLE OF PHARMACEUTICALS IN PUBLIC HEALTH ACCESS TO ESSENTIAL MEDI
by udeline
School of Public HealthTHE ROLE OF PHARMACEUTICALS...
Loxo Oncology Expanded Access Program (EAP)
Loxo Oncology Expanded Access Program (EAP)
by undialto
EAP Request Details - To be completed Requester Co...
Harm Reduction in a Housing Continuum
Harm Reduction in a Housing Continuum
by onionchevrolet
Kate Perch. Prevention Point Philadelphia. “. To...
Improving access to treatment of the NTDs – Challenges and measures
Improving access to treatment of the NTDs – Challenges and measures
by tatiana-dople
Dr. . Sultani. . Matendechero. Head, Kenya Natio...
Express Scripts Exclusions Target 25 Drug
Express Scripts Exclusions Target 25 Drug
by luanne-stotts
Classes. H. ave. low-cost. generic alternatives,....
Abuse-Deterrent Opioids:
Abuse-Deterrent Opioids:
by celsa-spraggs
FDA’s Role and . Emerging Challenges. Jeanne Ir...
[insert Speaker Name Date &
[insert Speaker Name Date &
by test
Location here]. Ethics of Tuberculosis Prevention...
Medication Access for Patients in Need
Medication Access for Patients in Need
by tawny-fly
ISAC Spring Conference. March 15, 2018. Donated m...
Community Drug and alcohol treatment and recovery services
Community Drug and alcohol treatment and recovery services
by yoshiko-marsland
Who are we?. Community drug and alcohol treatment...
Code Blue
Code Blue
by tawny-fly
Drug overdose. Arun Prasad Alagarsamy. Mukhar Gup...
Optimizing The 340B Program
Optimizing The 340B Program
by mitsue-stanley
Promoting Integrity, Access, & . Value. To de...
Workshop on IP & Access to Medicines at
Workshop on IP & Access to Medicines at
by min-jolicoeur
Cochin University of Science & Technology . S...
Sexual And Reproductive Health and Rights
Sexual And Reproductive Health and Rights
by luanne-stotts
NINI PAKMA. MEGHALAYA. INDIA. IAC 2014 . Melbourn...
Rationale for New Drugs for Tuberculosis
Rationale for New Drugs for Tuberculosis
by pamella-moone
500,000 cases annually of MDR TB. Second line tre...
Intellectual property rights:  innovation, Economics and Ac
Intellectual property rights: innovation, Economics and Ac
by min-jolicoeur
By Sanjay Jain. VP, . Quality . Management. Amne...
A Multi-Systemic Approach for Addressing Arizona’s “Sil
A Multi-Systemic Approach for Addressing Arizona’s “Sil
by pasty-toler
Shana Malone. Arizona Criminal Justice Commission...
HIV Treatment-as-Prevention (TasP) for people who use illic
HIV Treatment-as-Prevention (TasP) for people who use illic
by tatyana-admore
The North American experience. M-J . MILLOY. Rese...
x0000x0000  USA IRB Policy and Procedurex0000x0000Page of
x0000x0000 USA IRB Policy and Procedurex0000x0000Page of
by elena
�� USA IRB Policy and Procedure&#x0...
en focused on antibiotic therapies is approach has been referred to a
en focused on antibiotic therapies is approach has been referred to a
by eloise
R 5 Nwwwnaturecom/cptnature publishing groupSTATE...
[insert Speaker Name Date &
[insert Speaker Name Date &
by conchita-marotz
Location here]. Ethics of Tuberculosis Prevention...
Certification Program  Requirements*
Certification Program Requirements*
by stefany-barnette
2015 Edition Certification Criteria . Associated ...
Patrick McLaughlin National Library of Medicine
Patrick McLaughlin National Library of Medicine
by liane-varnes
National Institutes of Health. U.S. Department of...
HCV drug pricing « The future of HIV & HCV Treatment :
HCV drug pricing « The future of HIV & HCV Treatment :
by marina-yarberry
Patents, pricing and pharma, Special session » ...
Succeeding with  Programmes,
Succeeding with Programmes,
by cheryl-pisano
Failing with . the Law?. Michaela Clayton. Plenar...
CURE Government Affairs Meeting
CURE Government Affairs Meeting
by liane-varnes
& Annual Meeting. June 13, 2017. An Overview ...